Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
9.66
+0.03 (0.31%)
Aug 21, 2026, 4:00 PM EST

Knight Therapeutics Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
547.31450.09371.3328.2293.56243.48
Revenue Growth
42.32%21.22%13.13%11.80%20.57%22.03%
Gross Profit
259.26200.23174.41152.65138.06115.41
Operating Income
21.93-2.357.46.37-17.06-12.83
Net Income
14.87-5.374.33-16.84-29.8915.68
Earnings Per Share
0.15-0.050.04-0.16-0.260.13
EPS Growth
8835.08%-----60.55%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Brazil
207.96182.52180.63168.22134.7397.2
Canada
142.9384.2825.6919.6711.357.7
Colombia
61.855551.4844.6348.1543.52
Argentina
46.5240.7545.924.146.1342.96
Mexico
27.3724.518.9915.89--
Rest of The Latin America
37.8843.0238.8339.2240.1740.95
Other
22.8120.029.7816.4813.0511.15
Total
547.31450.09371.3328.2293.56243.48

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
121.17114.23172.84177.28200.78160.16
Total Debt
34.2877.9149.4669.0977.740.96
Net Cash (Debt)
86.936.32123.38108.18123.08119.2
Net Cash Growth
644.10%-70.56%14.04%-12.10%3.26%-67.36%
Net Cash Per Share
0.870.361.221.011.070.96

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
115.2568.9636.2835.944544.62
Capital Expenditures
-4.89-1.91-2.47-0.95-2.89-3.83
Free Cash Flow
110.3667.0533.8134.9942.1240.79
Free Cash Flow Growth
286.27%98.30%-3.37%-16.92%3.26%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
47.37%44.49%46.97%46.51%47.03%47.40%
Operating Margin
4.01%-0.52%1.99%1.94%-5.81%-5.27%
Pretax Margin
3.91%-1.49%0.55%-6.70%-14.97%2.75%
Profit Margin
2.72%-1.19%1.17%-5.13%-10.18%6.44%
FCF Margin
20.16%14.90%9.11%10.66%14.35%16.75%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
64.19-123.63--40.16
Forward PE
78.61201.67157.0679.2495.3782.43
P/FCF Ratio
8.578.9615.8415.4513.8615.44
PS Ratio
1.731.341.441.651.992.59